Hepatitis B, Chronic: all 954 studies
Page 8 of 10. Open to participants first (147), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker DiversityStatus unknownNCT02148562
- PROLIFICA - West African Treatment Cohort for Hepatitis BCompletedNCT02129829
- Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseTerminatedNCT02128503Not applicable
- Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver TransplantationCompletedNCT02125071
- Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
- Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B InfectionCompletedNCT02097004Phase 4
- Prophylaxis of CHB Patients With Malignant Tumor Receiving ChemotherapyCompletedNCT02081469Phase 4
- Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis BCompletedNCT02075294
- Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis BCompletedNCT02069678
- An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue TherapyCompletedNCT02068365Phase 4
- Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic MalignancyStatus unknownNCT02056548
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir BackgroundWithdrawnNCT02053727Not applicable
- Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal DiseasesWithdrawnNCT02049736Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination TherapyCompletedNCT02019966
- Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV InfectionStatus unknownNCT02017587
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide AnalogsCompletedNCT02005146
- Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With CholestasisStatus unknownNCT01998620Phase 4
- Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsCompletedNCT01997944Phase 1/2
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical TrialStatus unknownNCT01965418Phase 4
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Phase 3 and Extensional Study of BesifovirStatus unknownNCT01937806Phase 3
- A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
- Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyCompletedNCT01928511Phase 4
- Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis BCompletedNCT01913431Phase 4
- Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide AnaloguesStatus unknownNCT01911156Phase 4
- Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life ConditionsCompletedNCT01908660
- Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BStatus unknownNCT01906580Phase 4
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
- A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis BCompletedNCT01887275Phase 4
- The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg SeroconversionStatus unknownNCT01878565Phase 1/2
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute ExacerbationStatus unknownNCT01848743Phase 3
- 3E Extension StudyStatus unknownNCT01834508Phase 4
- Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALTStatus unknownNCT01833611Phase 4
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver FailureCompletedNCT01826760
- Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110ECompletedNCT01813487Not applicable
- Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) AnaloguesTerminatedNCT01794234
- Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in KoreaStatus unknownNCT01776814
- Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in IndiaCompletedNCT01772121
- HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside MaintenanceStatus unknownNCT01769833Phase 3
- Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01760122Phase 3
- Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis BCompletedNCT01734018
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- Study for Consolidation Period of Chronic Hepatitis BCompletedNCT01732354
- "Real-life" Cohort of Patients With Chronic Hepatitis B Virus InfectionStatus unknownNCT01732081
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT01730508
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)WithdrawnNCT01727271Phase 4
- Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in ChinaCompletedNCT01726439
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis BCompletedNCT01705704
- Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαTerminatedNCT01694264Phase 3
- Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis BCompletedNCT01679769
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265CompletedNCT01645969
- Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B PatientsCompletedNCT01641536Phase 1
- Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis BCompletedNCT01639092Phase 4
- Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis BCompletedNCT01639066Phase 4
- ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis BStatus unknownNCT01633554
- Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- HBV DNA Levels During Pregnancy in Chronic Hepatitis BStatus unknownNCT01610115
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedNCT01595685Phase 3
- Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination TherapyStatus unknownNCT01595633Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT01590654Phase 1
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis BCompletedNCT01590641Phase 1
- Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)Status unknownNCT01589952Phase 1/2
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- Resistance to Lamivudine in HBV Egyptian PatientsCompletedNCT01548820
- Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedNCT01546116Phase 4
- Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis BStatus unknownNCT01533051
- Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHBCompletedNCT01532843Phase 4
- A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated InterferonCompletedNCT01531166
- EFFORT Extension StudyStatus unknownNCT01529255Phase 4
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedNCT01521975Phase 4
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B PatientsStatus unknownNCT01487876Phase 2
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) InfectionCompletedNCT01480492Not applicable
- HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon TreatedCompletedNCT01471535Not applicable
- A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/mlStatus unknownNCT01464281Not applicable
- HBsAg Related Response Guided TherapyStatus unknownNCT01456312Phase 4
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ MothersCompletedNCT01412567Not applicable
- Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B StudyCompletedNCT01401400
- Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)Status unknownNCT01380951Phase 4
- Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)CompletedNCT01376154
- NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) PatientsStatus unknownNCT01374308Phase 3